Tuberculosis [clinicaltrials_resource:432448829b648dc1e44a7bde43af0238]
Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection [clinicaltrials:NCT00000636]Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection [clinicaltrials:NCT00000638]A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin [clinicaltrials:NCT00000778]A Registry of Tuberculosis Cases in the CPCRA [clinicaltrials:NCT00000785]A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients. [clinicaltrials:NCT00000796]Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis [clinicaltrials:NCT00000950]Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) Infection [clinicaltrials:NCT00000955]Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous Infection [clinicaltrials:NCT00000959]The Treatment of Tuberculosis in HIV-Infected Patients [clinicaltrials:NCT00001033]Phase II Placebo Controlled Study of Thalidomide in Patients With Mycobacterial and HIV Infections [clinicaltrials:NCT00004276]Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis [clinicaltrials:NCT00004736]Randomized Study of Interventions to Enhance Adherence to Isoniazid Prevention Therapy for Tuberculosis in Injection Drug Users [clinicaltrials:NCT00004740]Tuberculosis in a Multiethnic Inner City Population [clinicaltrials:NCT00005379]Tuberculosis Prophylaxis in the Homeless--A Controlled Trial [clinicaltrials:NCT00005737]Promoting Adherence to TB Regimens in Latino Adolescents [clinicaltrials:NCT00005738]Behavioral Interventions for Control of TB [clinicaltrials:NCT00005739]TB Contact Investigation: Behavioral Intervention [clinicaltrials:NCT00005740]Indigenous Outreach Among Injection Drug Users to Treat and Control TB [clinicaltrials:NCT00005741]Behavioral Interventions for Control of Tuberculosis [clinicaltrials:NCT00005742]Intensive Pharmacokinetics of the Nelfinavir-Rifabutin Interaction in Patients With HIV-Related Tuberculosis Treated With a Rifabutin-Based Regimen [clinicaltrials:NCT00018083]TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB [clinicaltrials:NCT00023348]TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen [clinicaltrials:NCT00023361]clinicaltrials:NCT00023374TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine [clinicaltrials:NCT00023387]TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB [clinicaltrials:NCT00023400]TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz [clinicaltrials:NCT00023413]TBTC Study 25: Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis [clinicaltrials:NCT00023426]TBTC NAA Study: Pilot Study of Surrogate Markers for Outcome of TB Treatment [clinicaltrials:NCT00023439]clinicaltrials:NCT00023452Investigational Vaccine for the Prevention of Disseminated Tuberculosis in HIV Infected People [clinicaltrials:NCT00052195]Diagnosing Tuberculosis in HIV Infected Children in Peru [clinicaltrials:NCT00054769]clinicaltrials:NCT00057122Tuberculosis in HIV Infected Patients in Uganda [clinicaltrials:NCT00057421]Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis [clinicaltrials:NCT00078247]clinicaltrials:NCT00080119clinicaltrials:NCT00082173Effectiveness of Directly Observed Therapy in Combined HIV and Tuberculosis Treatment in Resource-limited Settings [clinicaltrials:NCT00091936]clinicaltrials:NCT00096681clinicaltrials:NCT00096850clinicaltrials:NCT00107887
condition [clinicaltrials_vocabulary:condition]
Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection [clinicaltrials:NCT00000636]Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection [clinicaltrials:NCT00000638]A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin [clinicaltrials:NCT00000778]A Registry of Tuberculosis Cases in the CPCRA [clinicaltrials:NCT00000785]A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients. [clinicaltrials:NCT00000796]Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis [clinicaltrials:NCT00000950]Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) Infection [clinicaltrials:NCT00000955]Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous Infection [clinicaltrials:NCT00000959]The Treatment of Tuberculosis in HIV-Infected Patients [clinicaltrials:NCT00001033]Interferon Gamma for Drug Resistant Tuberculosis [clinicaltrials:NCT00001407]A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy [clinicaltrials:NCT00002085]Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIV [clinicaltrials:NCT00002104]Phase II Placebo Controlled Study of Thalidomide in Patients With Mycobacterial and HIV Infections [clinicaltrials:NCT00004276]Pilot Randomized Study of Paromomycin (Aminosidine) vs Streptomycin for Uncomplicated Pulmonary Tuberculosis [clinicaltrials:NCT00004444]Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis [clinicaltrials:NCT00004736]Randomized Study of Interventions to Enhance Adherence to Isoniazid Prevention Therapy for Tuberculosis in Injection Drug Users [clinicaltrials:NCT00004740]Tuberculosis in a Multiethnic Inner City Population [clinicaltrials:NCT00005379]Tuberculosis Prophylaxis in the Homeless--A Controlled Trial [clinicaltrials:NCT00005737]Promoting Adherence to TB Regimens in Latino Adolescents [clinicaltrials:NCT00005738]Behavioral Interventions for Control of TB [clinicaltrials:NCT00005739]TB Contact Investigation: Behavioral Intervention [clinicaltrials:NCT00005740]Indigenous Outreach Among Injection Drug Users to Treat and Control TB [clinicaltrials:NCT00005741]Behavioral Interventions for Control of Tuberculosis [clinicaltrials:NCT00005742]Intensive Pharmacokinetics of the Nelfinavir-Rifabutin Interaction in Patients With HIV-Related Tuberculosis Treated With a Rifabutin-Based Regimen [clinicaltrials:NCT00018083]TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis [clinicaltrials:NCT00023335]TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB [clinicaltrials:NCT00023348]TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen [clinicaltrials:NCT00023361]clinicaltrials:NCT00023374TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine [clinicaltrials:NCT00023387]TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB [clinicaltrials:NCT00023400]TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz [clinicaltrials:NCT00023413]TBTC Study 25: Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis [clinicaltrials:NCT00023426]TBTC NAA Study: Pilot Study of Surrogate Markers for Outcome of TB Treatment [clinicaltrials:NCT00023439]clinicaltrials:NCT00023452Investigational Vaccine for the Prevention of Disseminated Tuberculosis in HIV Infected People [clinicaltrials:NCT00052195]Diagnosing Tuberculosis in HIV Infected Children in Peru [clinicaltrials:NCT00054769]clinicaltrials:NCT00057122Tuberculosis in HIV Infected Patients in Uganda [clinicaltrials:NCT00057421]Vitamin A Therapy for Tuberculosis [clinicaltrials:NCT00057434]Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis [clinicaltrials:NCT00078247]
condition browse [clinicaltrials_vocabulary:condition-browse]
Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection [clinicaltrials:NCT00000636]Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection [clinicaltrials:NCT00000638]A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin [clinicaltrials:NCT00000778]A Registry of Tuberculosis Cases in the CPCRA [clinicaltrials:NCT00000785]A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients. [clinicaltrials:NCT00000796]Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis [clinicaltrials:NCT00000950]Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) Infection [clinicaltrials:NCT00000955]Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous Infection [clinicaltrials:NCT00000959]The Treatment of Tuberculosis in HIV-Infected Patients [clinicaltrials:NCT00001033]Interferon Gamma for Drug Resistant Tuberculosis [clinicaltrials:NCT00001407]A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy [clinicaltrials:NCT00002085]Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIV [clinicaltrials:NCT00002104]Phase II Placebo Controlled Study of Thalidomide in Patients With Mycobacterial and HIV Infections [clinicaltrials:NCT00004276]Pilot Randomized Study of Paromomycin (Aminosidine) vs Streptomycin for Uncomplicated Pulmonary Tuberculosis [clinicaltrials:NCT00004444]Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis [clinicaltrials:NCT00004736]Randomized Study of Interventions to Enhance Adherence to Isoniazid Prevention Therapy for Tuberculosis in Injection Drug Users [clinicaltrials:NCT00004740]Tuberculosis in a Multiethnic Inner City Population [clinicaltrials:NCT00005379]Tuberculosis Prophylaxis in the Homeless--A Controlled Trial [clinicaltrials:NCT00005737]Promoting Adherence to TB Regimens in Latino Adolescents [clinicaltrials:NCT00005738]Behavioral Interventions for Control of TB [clinicaltrials:NCT00005739]TB Contact Investigation: Behavioral Intervention [clinicaltrials:NCT00005740]Indigenous Outreach Among Injection Drug Users to Treat and Control TB [clinicaltrials:NCT00005741]Behavioral Interventions for Control of Tuberculosis [clinicaltrials:NCT00005742]Intensive Pharmacokinetics of the Nelfinavir-Rifabutin Interaction in Patients With HIV-Related Tuberculosis Treated With a Rifabutin-Based Regimen [clinicaltrials:NCT00018083]TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis [clinicaltrials:NCT00023335]TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB [clinicaltrials:NCT00023348]TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen [clinicaltrials:NCT00023361]clinicaltrials:NCT00023374TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine [clinicaltrials:NCT00023387]TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB [clinicaltrials:NCT00023400]TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz [clinicaltrials:NCT00023413]TBTC Study 25: Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis [clinicaltrials:NCT00023426]TBTC NAA Study: Pilot Study of Surrogate Markers for Outcome of TB Treatment [clinicaltrials:NCT00023439]clinicaltrials:NCT00023452Investigational Vaccine for the Prevention of Disseminated Tuberculosis in HIV Infected People [clinicaltrials:NCT00052195]Diagnosing Tuberculosis in HIV Infected Children in Peru [clinicaltrials:NCT00054769]clinicaltrials:NCT00057122Tuberculosis in HIV Infected Patients in Uganda [clinicaltrials:NCT00057421]Vitamin A Therapy for Tuberculosis [clinicaltrials:NCT00057434]Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis [clinicaltrials:NCT00078247]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Tuberculosis [clinicaltrials_resource:432448829b648dc1e44a7bde43af0238]
Bio2RDF identifier
432448829b648dc1e44a7bde43af0238
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:432448829b648dc1e44a7bde43af0238
identifier
clinicaltrials_resource:432448829b648dc1e44a7bde43af0238
title
Tuberculosis
@en
type
label
Tuberculosis [clinicaltrials_resource:432448829b648dc1e44a7bde43af0238]
@en
Tuberculosis